COMMD3
gene geneOn this page
Also known as BUP
Summary
COMMD3 (COMM domain containing 3, HGNC:23332) is a protein-coding gene on chromosome 10p12.2, encoding COMM domain-containing protein 3 (Q9UBI1). Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex.
Predicted to be involved in endocytic recycling. Predicted to act upstream of or within intracellular copper ion homeostasis. Part of protein-containing complex.
Source: NCBI Gene 23412 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 9 total
- GTEx eGene: eQTL in 11 tissues, sQTL in 1 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.33 (unconstrained)
- MANE Select transcript:
NM_012071
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23332 |
| Approved symbol | COMMD3 |
| Name | COMM domain containing 3 |
| Location | 10p12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BUP |
| Ensembl gene | ENSG00000148444 |
| Ensembl biotype | protein_coding |
| OMIM | 616700 |
| Entrez | 23412 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 15 protein_coding, 10 nonsense_mediated_decay, 6 retained_intron, 3 protein_coding_CDS_not_defined
MANE Select: ENST00000376836
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2, TSL 2: 5, TSL 3: 4, TSL 5: 4
ENST00000376836, ENST00000444869, ENST00000448361, ENST00000456711, ENST00000463688, ENST00000468179, ENST00000468469, ENST00000470045, ENST00000471350, ENST00000472610, ENST00000472673, ENST00000479958, ENST00000483684, ENST00000496071, ENST00000602574, ENST00000860458, ENST00000860459, ENST00000860460, ENST00000860461, ENST00000964928, ENST00000999519, ENST00000999520, ENST00000999521, ENST00001041057, ENST00001041058, ENST00001041060, ENST00001041061, ENST00001099960, ENST00001099961, ENST00001099962, ENST00001099963, ENST00001099964, ENST00001119572, ENST00001137339
RefSeq mRNA: 1 — MANE Select: NM_012071
NM_012071
CCDS: CCDS7137
Canonical transcript exons
ENST00000376836 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001822108 | 22316388 | 22316556 |
| ENSE00003496732 | 22317884 | 22317995 |
| ENSE00003555854 | 22318272 | 22318306 |
| ENSE00003558432 | 22318806 | 22318862 |
| ENSE00003611347 | 22318959 | 22319018 |
| ENSE00003620155 | 22319939 | 22320306 |
| ENSE00003620718 | 22318105 | 22318168 |
| ENSE00003623512 | 22318653 | 22318713 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 97.92.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0299 / max 4.2606, expressed in 14 samples.
Highest expression (Bgee): diaphragm, body of pancreas, triceps brachii, parotid gland, cortical plate.
Genetic regulation across tissues (GTEx eQTL / sQTL)
COMMD3 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 11 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
12 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Thyroid | eqtl | 2.7e-04 | +0.30 | 10:22313171:C:G |
| Artery Tibial | eqtl | 5.4e-03 | -0.32 | 10:23067782:C:T |
| Esophagus Muscularis | eqtl | 7.1e-03 | +0.30 | 10:21876772:C:G |
| Pancreas | eqtl | 8.1e-03 | +0.37 | 10:22275669:G:A |
| Colon Transverse | sqtl | 1.2e-02 | -1.79 | 10:22348150:C:G |
| Skin Not Sun Exposed Suprapubic | eqtl | 2.2e-02 | +0.14 | 10:22499231:C:T |
| Cells Cultured fibroblasts | eqtl | 2.4e-02 | +0.23 | 10:22319242:C:G |
| Brain Cerebellar Hemisphere | eqtl | 2.9e-02 | +0.55 | 10:22279215:C:T |
| Heart Atrial Appendage | eqtl | 3.2e-02 | +0.33 | 10:23142679:T:C |
| Vagina | eqtl | 3.4e-02 | +1.30 | 10:21650672:A:G |
| Testis | eqtl | 3.8e-02 | -0.33 | 10:22013510:T:C |
| Colon Sigmoid | eqtl | 4.4e-02 | +0.51 | 10:22281462:G:A |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 104230 | 62.2653 | 1826 |
| 104234 | 0.0299 | 14 |
Top tissues by expression
showing 100 of 288 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| diaphragm | UBERON:0001103 | 97.92 | gold quality |
| body of pancreas | UBERON:0001150 | 97.48 | gold quality |
| triceps brachii | UBERON:0001509 | 97.13 | gold quality |
| parotid gland | UBERON:0001831 | 97.08 | gold quality |
| cortical plate | UBERON:0005343 | 97.02 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.92 | gold quality |
| thymus | UBERON:0002370 | 96.64 | gold quality |
| heart right ventricle | UBERON:0002080 | 96.58 | gold quality |
| biceps brachii | UBERON:0001507 | 96.54 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 96.47 | gold quality |
| monocyte | CL:0000576 | 96.46 | gold quality |
| mononuclear cell | CL:0000842 | 96.43 | gold quality |
| heart left ventricle | UBERON:0002084 | 96.41 | gold quality |
| olfactory bulb | UBERON:0002264 | 96.41 | silver quality |
| cardiac ventricle | UBERON:0002082 | 96.40 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.37 | gold quality |
| left testis | UBERON:0004533 | 96.36 | gold quality |
| myocardium | UBERON:0002349 | 96.34 | gold quality |
| cardiac atrium | UBERON:0002081 | 96.31 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.30 | gold quality |
| vastus lateralis | UBERON:0001379 | 96.28 | gold quality |
| leukocyte | CL:0000738 | 96.27 | gold quality |
| right testis | UBERON:0004534 | 96.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 96.22 | gold quality |
| gluteal muscle | UBERON:0002000 | 96.19 | gold quality |
| heart | UBERON:0000948 | 96.17 | gold quality |
| superficial temporal artery | UBERON:0001614 | 96.10 | gold quality |
| pituitary gland | UBERON:0000007 | 96.08 | gold quality |
| pancreas | UBERON:0001264 | 96.07 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.05 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.02 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.96 | gold quality |
| type B pancreatic cell | CL:0000169 | 95.95 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.90 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 95.88 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.87 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 95.80 | gold quality |
| right uterine tube | UBERON:0001302 | 95.79 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.77 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.77 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 95.77 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 95.75 | gold quality |
| testis | UBERON:0000473 | 95.74 | gold quality |
| rectum | UBERON:0001052 | 95.74 | gold quality |
| minor salivary gland | UBERON:0001830 | 95.63 | gold quality |
| lymph node | UBERON:0000029 | 95.61 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 95.58 | gold quality |
| muscle organ | UBERON:0001630 | 95.57 | gold quality |
| hair follicle | UBERON:0002073 | 95.57 | gold quality |
| skin of abdomen | UBERON:0001416 | 95.54 | gold quality |
| deltoid | UBERON:0001476 | 95.48 | gold quality |
| mouth mucosa | UBERON:0003729 | 95.48 | gold quality |
| periodontal ligament | UBERON:0008266 | 95.45 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 95.43 | gold quality |
| muscle of leg | UBERON:0001383 | 95.43 | gold quality |
| spinal cord | UBERON:0002240 | 95.43 | gold quality |
| cerebellum | UBERON:0002037 | 95.41 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.38 | gold quality |
| muscle tissue | UBERON:0002385 | 95.37 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.37 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 95.33 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 95.30 | gold quality |
| male germ cell | CL:0000015 | 95.29 | gold quality |
| gingival epithelium | UBERON:0001949 | 95.29 | gold quality |
| spleen | UBERON:0002106 | 95.27 | gold quality |
| lower esophagus | UBERON:0013473 | 95.27 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.27 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.27 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.24 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 95.21 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.21 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 95.20 | gold quality |
| cervix epithelium | UBERON:0004801 | 95.18 | gold quality |
| skin of leg | UBERON:0001511 | 95.13 | gold quality |
| gingiva | UBERON:0001828 | 95.13 | gold quality |
| bronchus | UBERON:0002185 | 95.12 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.10 | gold quality |
| apex of heart | UBERON:0002098 | 95.09 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 95.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 95.08 | gold quality |
| zone of skin | UBERON:0000014 | 95.08 | gold quality |
| sperm | CL:0000019 | 95.07 | gold quality |
| bone marrow | UBERON:0002371 | 95.06 | gold quality |
| body of tongue | UBERON:0011876 | 95.06 | gold quality |
| right coronary artery | UBERON:0001625 | 95.05 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 95.04 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.02 | gold quality |
| left coronary artery | UBERON:0001626 | 95.00 | gold quality |
| transverse colon | UBERON:0001157 | 94.99 | gold quality |
| bronchial epithelial cell | CL:0002328 | 94.97 | gold quality |
| gall bladder | UBERON:0002110 | 94.94 | gold quality |
| ascending aorta | UBERON:0001496 | 94.92 | gold quality |
| thoracic aorta | UBERON:0001515 | 94.92 | gold quality |
| vermiform appendix | UBERON:0001154 | 94.90 | gold quality |
| body of uterus | UBERON:0009853 | 94.85 | gold quality |
| right lung | UBERON:0002167 | 94.83 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.80 | gold quality |
| large intestine | UBERON:0000059 | 94.79 | gold quality |
| colon | UBERON:0001155 | 94.79 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.75 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-46 | yes | 33.70 |
| E-ANND-3 | yes | 19.51 |
| E-GEOD-36552 | no | 39.91 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 79 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Frontal cortex | tissue | 100.0 | |
| Caudate putamen | tissue | 92.9 | |
| Heart muscle | tissue | 74.7 | low |
| Corpus callosum | tissue | 72.6 | |
| Tongue | tissue | 71.0 | |
| Skeletal muscle | tissue | 70.7 | medium |
| Spinal cord | tissue | 66.6 | |
| Substantia nigra | tissue | 64.3 | |
| Medulla oblongata | tissue | 62.8 | |
| Pons | tissue | 62.4 | |
| Hippocampal formation | tissue | 61.8 | |
| Superior colliculi | tissue | 61.6 | |
| Midbrain | tissue | 61.4 | |
| Thalamus | tissue | 59.5 | |
| Liver | tissue | 58.7 | medium |
| Putamen | tissue | 57.9 | |
| Cerebellum | tissue | 57.9 | low |
| Septum | tissue | 57.2 | |
| Thymus | tissue | 57.0 | |
| Hypothalamus | tissue | 55.6 | |
| Olfactory bulb | tissue | 54.7 | |
| Periaqueductal gray | tissue | 53.1 | |
| Prefrontal cortex | tissue | 50.3 | |
| Cerebral cortex | tissue | 50.3 | medium |
| Parathyroid gland | tissue | 50.2 | low |
| Ventral forebrain | tissue | 50.2 | |
| Motor cortex | tissue | 49.9 | |
| Breast | tissue | 49.3 | high |
| Somatosensory cortex | tissue | 49.0 | |
| Occipital cortex | tissue | 49.0 | |
| Salivary gland | tissue | 48.8 | high |
| Pancreas | tissue | 48.7 | high |
| Retrosplenial and cingulate cortex | tissue | 47.1 | |
| Basal ganglia | tissue | 46.9 | medium |
| Entorhinal cortex | tissue | 46.4 | |
| Temporal cortex | tissue | 45.8 | |
| Epididymis | tissue | 45.1 | medium |
| Retrosplenial cortex | tissue | 45.1 | |
| Insular cortex | tissue | 44.0 | |
| Amygdala | tissue | 43.6 | |
| Lymph node | tissue | 42.4 | low |
| Tonsil | tissue | 40.7 | medium |
| Urinary bladder | tissue | 37.1 | high |
| Smooth muscle | tissue | 36.4 | low |
| Ovary | tissue | 36.3 | medium |
| Appendix | tissue | 36.1 | medium |
| Kidney | tissue | 36.0 | high |
| Bone marrow | tissue | 36.0 | high |
| Esophagus | tissue | 35.8 | medium |
| Colon | tissue | 35.8 | medium |
| Duodenum | tissue | 35.3 | medium |
| Pituitary gland | tissue | 35.1 | |
| Rectum | tissue | 34.6 | medium |
| Small intestine | tissue | 34.6 | medium |
| Skin 1 | tissue | 34.5 | medium |
| Prostate | tissue | 34.4 | medium |
| Adrenal gland | tissue | 33.3 | medium |
| Fallopian tube | tissue | 32.6 | high |
| Stomach 1 | tissue | 31.1 | medium |
| Thyroid gland | tissue | 31.0 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — White matter (72.6), Ventral spinal cord (66.6), Dorsal spinal cord (66.0), Dorsal hippocampus (61.8), Ventral hippocampus (51.6).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting COMMD3 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
19 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-29B-1-5P | 98.86 | 68.35 | 1364 |
| HSA-MIR-6794-3P | 98.76 | 66.99 | 894 |
| HSA-MIR-4520-3P | 98.75 | 66.55 | 963 |
| HSA-MIR-6780A-3P | 98.42 | 67.49 | 1518 |
| HSA-MIR-138-1-3P | 98.25 | 67.89 | 867 |
| HSA-MIR-12126 | 98.09 | 64.82 | 637 |
| HSA-MIR-6881-3P | 98.04 | 68.24 | 1777 |
| HSA-MIR-506-5P | 98.02 | 67.41 | 1065 |
| HSA-MIR-7111-3P | 97.80 | 66.75 | 1467 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
Functional genomics
gnomAD constraint: pLI 4.7e-11, LOEUF 1.33, missense Z -0.843 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000376836 — one region, missense o/e 1.16.
Literature-anchored findings (GeneRIF, showing 6)
- complex determines GRK6 specificity for chemoattractant receptors (PMID:31088898)
- Data show that COMMD3 level is elevated in prostate cancer cell models, PDX models, and metastases. A positive correlation between increased COMMD3 expression and disease recurrence and poor survival was found. COMMD3 drives proliferation of normal cells and promotes migration/invasiveness of neoplastic cells. COMMD3:BMI1 fusion protein and COMMD3 regulate C-MYC transcription and C-MYC downstream pathway. (PMID:31467179)
- Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. (PMID:34493238)
- Syntaxin 12 and COMMD3 are new factors that function with VPS33B in the biogenesis of platelet alpha-granules. (PMID:34905616)
- COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma. (PMID:36445330)
- COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. (PMID:37072858)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | commd3 | ENSDARG00000045402 |
| mus_musculus | Commd3 | ENSMUSG00000051154 |
| rattus_norvegicus | Commd3 | ENSRNOG00000016383 |
| drosophila_melanogaster | CG12106 | FBGN0030100 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:88218) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 13 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| increased body length | 1 |
| decreased IgM level | 1 |
| increased lean body mass | 1 |
| decreased follicular B cell number | 1 |
| abnormal follicular B cell physiology | 1 |
| decreased mature B cell number | 1 |
| abnormal spleen B cell follicle morphology | 1 |
| decreased spleen germinal center number | 1 |
| decreased IgG1 level | 1 |
| decreased IgG2b level | 1 |
| decreased IgG2c level | 1 |
| increased total body fat amount | 1 |
| abnormal plasmablast number | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q3SZ76 | 91.8% | Diamond |
| Dictyostelium discoideum | Q54QK4 | 32.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| TRN-GTT2-3 | tRNA | 100189083 |
| COMMD3-BMI1 | protein-coding | 100532731 |
| LINC03027 | ncRNA | 100499489 |
| BMI1 | protein-coding | 648 |
| SPAG6 | protein-coding | 9576 |
Protein
Protein identifiers
COMM domain-containing protein 3 — Q9UBI1 (reviewed: Q9UBI1)
Alternative names: Protein Bup, Protein PIL
All UniProt accessions (6): Q9UBI1, H0Y4E5, H0Y4W0, H0Y6Z9, R4GN06, R4GNF2
UniProt curated annotations — full annotation on UniProt →
Function. Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex. May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes. May down-regulate activation of NF-kappa-B. Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits.
Subunit / interactions. Component of the commander complex consisting of the CCC subcomplex and the retriever subcomplex. Component of the CCC (COMMD/CCDC22/CCDC93) subcomplex consisting of COMMD1, COMMD2, COMMD3, COMMD4, COMMD5, COMMD6, COMMD7, COMMD8, COMMD9, COMMD10, CCDC22 and CCDC93; within the complex forms a heterodimer with COMMD2. Interacts with NFKB1/p105. Interacts with CCDC22, CCDC93, SCNN1B, CUL3, CUL4A, CUL4B, CUL5.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Widely expressed with highest expression in thymus.
Similarity. Belongs to the COMM domain-containing protein 3 family.
RefSeq proteins (1): NP_036203* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR017920 | COMM | Domain |
| IPR037355 | COMMD3 | Family |
Pfam: PF07258, PF21672
UniProt features (15 total): helix 6, strand 3, turn 3, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
3 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 8P0W | Structure of the human Commander complex COMMD ring | ELECTRON MICROSCOPY | 2.9 |
| 8F2R | Human CCC complex | ELECTRON MICROSCOPY | 3.12 |
| 8F2U | Human CCC complex | ELECTRON MICROSCOPY | 3.53 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UBI1-F1 | 86.84 | 0.63 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 6; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
6 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-168256 | Immune System | — |
| R-HSA-168249 | Innate Immune System | — |
| R-HSA-392499 | Metabolism of proteins | — |
| R-HSA-8951664 | Neddylation | — |
| R-HSA-6798695 | Neutrophil degranulation | — |
| R-HSA-597592 | Post-translational protein modification | — |
MSigDB gene sets: 178 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, BENPORATH_ES_WITH_H3K27ME3, GOCC_SECRETORY_GRANULE, TGACCTY_ERR1_Q2, GOBP_VESICLE_MEDIATED_TRANSPORT, CAGCTG_AP4_Q5, GOBP_MONOATOMIC_CATION_TRANSPORT, USF_01, TGACATY_UNKNOWN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, AACTTT_UNKNOWN, BENPORATH_NOS_TARGETS, GOBP_ENDOCYTIC_RECYCLING, USF_02, GOBP_LOCALIZATION_WITHIN_MEMBRANE
GO Biological Process (4): DNA-templated transcription (GO:0006351), sodium ion transport (GO:0006814), endocytic recycling (GO:0032456), monoatomic ion transport (GO:0006811)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): extracellular region (GO:0005576), nucleus (GO:0005634), endosome membrane (GO:0010008), protein-containing complex (GO:0032991), ficolin-1-rich granule lumen (GO:1904813), cytoplasm (GO:0005737), endoplasmic reticulum membrane (GO:0005789)
Reactome top-level categories
4 top-level categories:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
| Post-translational protein modification | 1 |
| Immune System | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
19 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| metal ion transport | 1 |
| endosomal transport | 1 |
| vesicle-mediated transport to the plasma membrane | 1 |
| transport | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| endosome | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| cellular_component | 1 |
| intracellular organelle lumen | 1 |
| ficolin-1-rich granule | 1 |
| intracellular anatomical structure | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 12 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| protein-containing complex | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,021 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COMMD3 | COMMD2 | Q86X83 | 809 |
| COMMD3 | COMMD4 | Q9H0A8 | 771 |
| COMMD3 | COMMD8 | Q9NX08 | 771 |
| COMMD3 | COMMD5 | Q9GZQ3 | 756 |
| COMMD3 | COMMD9 | Q9P000 | 736 |
| COMMD3 | CCDC22 | O60826 | 720 |
| COMMD3 | COMMD1 | Q8N668 | 716 |
| COMMD3 | CCDC93 | Q567U6 | 690 |
| COMMD3 | COMMD6 | Q7Z4G1 | 684 |
| COMMD3 | COMMD10 | Q9Y6G5 | 683 |
| COMMD3 | A0A2R8Y455 | A0A2R8Y455 | 644 |
| COMMD3 | COMMD7 | Q86VX2 | 634 |
| COMMD3 | DENND10 | Q8TCE6 | 632 |
| COMMD3 | VPS35L | Q7Z3J2 | 631 |
| COMMD3 | VPS26C | O14972 | 599 |
IntAct
Human interaction partners of COMMD3 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
showing 30 of 76 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| CCDC22 | physical association | 0.930 | 1 |
| COMMD2 | physical association | 0.900 | 3 |
| COMMD1 | physical association | 0.880 | 2 |
| CCDC93 | physical association | 0.850 | 1 |
| COMMD8 | physical association | 0.840 | 1 |
| VPS26C | association | 0.640 | 5 |
| AHNAK | direct interaction | 0.590 | 1 |
| PIH1D2 | physical association | 0.560 | 5 |
| PATJ | direct interaction | 0.440 | 7 |
| GRIP2 | direct interaction | 0.440 | 4 |
| DLG4 | direct interaction | 0.440 | 3 |
| GRIP1 | direct interaction | 0.440 | 3 |
| IL16 | direct interaction | 0.440 | 3 |
| MAGI2 | direct interaction | 0.440 | 3 |
| MPDZ | direct interaction | 0.440 | 3 |
| NHERF4 | direct interaction | 0.440 | 3 |
| APBA1 | direct interaction | 0.440 | 2 |
| APBA2 | direct interaction | 0.440 | 2 |
| DLG1 | direct interaction | 0.440 | 2 |
| GRID2IP | direct interaction | 0.440 | 2 |
| LNX1 | direct interaction | 0.440 | 2 |
| PDZK1 | direct interaction | 0.440 | 2 |
| WHRN | direct interaction | 0.440 | 2 |
| APBA3 | direct interaction | 0.440 | 1 |
| ARHGAP21 | direct interaction | 0.440 | 1 |
| ARHGEF11 | direct interaction | 0.440 | 1 |
| ARHGEF12 | direct interaction | 0.440 | 1 |
| CARD11 | direct interaction | 0.440 | 1 |
| CASK | direct interaction | 0.440 | 1 |
| DLG3 | direct interaction | 0.440 | 1 |
BioGRID (157 interactions; top human partners by supporting records): COMMD2 (Affinity Capture-MS; 7 records), COMMD8 (Affinity Capture-MS; 7 records), CCDC22 (Affinity Capture-MS; 6 records), COMMD1 (Affinity Capture-MS; 6 records), COMMD10 (Affinity Capture-MS; 6 records), CCDC93 (Affinity Capture-MS; 5 records), COMMD6 (Affinity Capture-MS; 5 records), COMMD9 (Affinity Capture-MS; 5 records), C16orf62 (Affinity Capture-MS; 4 records), COMMD4 (Affinity Capture-MS; 4 records), COMMD7 (Affinity Capture-MS; 4 records), DSCR3 (Affinity Capture-MS; 4 records), CCDC151 (Affinity Capture-MS; 3 records), CD33 (Affinity Capture-MS; 3 records), COMMD5 (Affinity Capture-MS; 3 records)
Protein complexes (CORUM) (2)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
2 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| CCC-Wash (WASH1, FAM21C) complex | 15 | COMMD3, COMMD4, CCDC22, COMMD1, COMMD8, WASHC1, WASHC2C, CCDC93, COMMD10, COMMD2, COMMD5, COMMD7, COMMD6, COMMD9, VPS35L |
| CCC complex | 13 | COMMD2, COMMD3, COMMD6, COMMD8, VPS35L, CCDC93, COMMD1, COMMD10, COMMD4, COMMD5, COMMD7, COMMD9, CCDC22 |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 76 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Assembly and cell surface presentation of NMDA receptors | 8 | 39.8× | 2e-09 |
| Neurexins and neuroligins | 9 | 34.8× | 7e-10 |
| Protein-protein interactions at synapses | 6 | 31.2× | 2e-06 |
| RHOA GTPase cycle | 5 | 7.3× | 6e-03 |
| Neuronal System | 6 | 5.2× | 9e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 10 | 78.5× | 1e-14 |
| protein localization to synapse | 5 | 51.8× | 4e-06 |
| receptor clustering | 6 | 50.6× | 4e-07 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 6 | 40.2× | 1e-06 |
| protein-containing complex assembly | 9 | 13.8× | 2e-06 |
| cell-cell adhesion | 7 | 9.6× | 4e-04 |
| chemical synaptic transmission | 6 | 6.3× | 8e-03 |
| protein transport | 8 | 4.7× | 7e-03 |
Disease & clinical
Genetic variants
Variant evidence for COMMD3: 9 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 23 predictions of 593):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 10:22316557–22316558 | donor_loss | 1.0000 | 4 |
| 10:22318441 | donor_gain | 1.0000 | |
| 10:22316557 | donor_loss | 0.9900 | |
| 10:22317996–22317997 | donor_loss | 0.9800 | 6 |
| 10:22318423 | donor_gain | 0.9700 | |
| 10:22318873 | donor_gain | 0.9600 | |
| 10:22316553 | donor_gain | 0.9500 | |
| 10:22317881–22317883 | acceptor_loss | 0.9500 | 6 |
| 10:22317883 | acceptor_loss | 0.9400 | |
| 10:22317995 | donor_loss | 0.9400 |
AlphaMissense
254 missense substitutions predicted likely pathogenic (of 1,280 scored), across 82 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F168 | 8 | 0.827 | 0.964 |
| D177 | 8 | 0.774 | 0.896 |
| D184 | 8 | 0.759 | 0.940 |
| W130 | 7 | 0.961 | 0.995 |
| C170 | 6 | 0.861 | 0.978 |
| F25 | 6 | 0.807 | 0.924 |
| K183 | 5 | 0.873 | 0.953 |
| K187 | 5 | 0.861 | 0.927 |
| K75 | 5 | 0.840 | 0.940 |
| K60 | 5 | 0.819 | 0.888 |
| Y104 | 5 | 0.813 | 0.960 |
| F100 | 5 | 0.795 | 0.900 |
| G180 | 5 | 0.722 | 0.841 |
| E72 | 5 | 0.699 | 0.771 |
| D127 | 5 | 0.691 | 0.825 |
| Y149 | 4 | 0.905 | 0.975 |
| F33 | 4 | 0.901 | 0.931 |
| L182 | 4 | 0.881 | 0.989 |
| Q176 | 4 | 0.855 | 0.926 |
| R191 | 4 | 0.797 | 0.881 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
4 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 7.06e-08 |
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 4.56e-06 |
| Glioblastoma Multiforme (validation) | favorable | 5.16e-05 |
| Kidney Renal Papillary Cell Carcinoma (TCGA) | favorable | 0.000601 |
Disease associations
OMIM: gene MIM:616700 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST004093_34 | Prostate-specific antigen levels | 1e-14 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases methylation, increases expression | 5 |
| Tobacco Smoke Pollution | decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| methylparaben | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| cupric chloride | decreases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| 1-nitropyrene | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Decitabine | affects expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | affects expression | 1 |
| Dimethyl Sulfoxide | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Selenium | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.